← Eichor
Study identifier: NCT06192940 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Impact of Smart Connected Insulin Pens on Quality of Life in Dependent Patients with Diabetes Using Continuous Glucose Measurement

Condition: Diabetes  ·  Sponsor: Centre Hospitalier Sud Francilien

PhaseN/A
Planned participants30
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Insulin-treated diabetes in dependent or institutionalized patients is often poorly balanced and continuous glucose measurement is underused. The purpose of this tudy is to know how smart connected insulin pens and continuous glucose measurement can improve insulin therapy practice in dependent and/or institutionalized patients?

This description comes directly from the study's public registry record.

Talk to the study team

Marie BOULY, APN  ·  01 61 69 35 93  ·  marie.bouly@chsf.fr

Caroline TOURTE  ·  01 61 69 31 50  ·  caroline.tourte@chsf.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Centre Hospitalier Sud FrancilienCorbeil-Essonnes, France, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06192940